Protagonist Therapeutics, Inc PTGX
- PN-477 — Obesity Phase 1
- PN-458 — Obesity Preclinical
- PN-458 — Obesity Preclinical
GIPR (2 companies · 5 programs)
Companies with an active program directed at GIPR.
Viking Therapeutics, Inc. VKTX
- VK2735 — Obesity Phase 3
- VK2735 — Obesity Phase 2